β2-agonist clenbuterol induced changes in the distribution of white blood cells in rats

Ken Shirato, Jun Tanihata, Norio Motohashi, Kaoru Tachiyashiki, Akio Tomoda, Kazuhiko Imaizumi

    Research output: Contribution to journalArticle

    22 Citations (Scopus)

    Abstract

    Clenbuterol [CLE: 4-amino-α(t-butyl-amino)methyl-3,5-dichlorobenzyl alcohol] is well known as a potent β2-adrenergic agonist and non-steroidal anabolic drug, and thus it is generally used for sports doping and asthma therapy. Although the functions of immune cells such as white blood cells (WBCs) have shown to be modulated through β2- adrenoceptors, the effects of CLE on immune-responsive systems have not been elucidated systematically. Therefore, the effects of CLE on the number of WBCs were studied in rats. Male adult rats were divided into CLE-administered group and the control group to compare the number of total WBCs, neutrophils, monocytes, lymphocytes, eosinophils, and basophils. The administration (dose = 1.0 mg·kg-1 body weight·day-1, s.c.) of CLE was maintained for 30 days. CLE did not change the number of total WBCs during the experimental period. However, CLE increased significantly the number of neutrophils and monocytes, while CLE decreased drastically the number of lymphocytes and eosinophils. There was no significant change in the number of basophils between both groups. These results suggest that the administration of CLE induces drastic redistribution of WBCs in circulation without changing the number of total WBCs, and these responses of WBCs during the administration of CLE are sustained for at least 30 days.

    Original languageEnglish
    Pages (from-to)146-152
    Number of pages7
    JournalJournal of Pharmacological Sciences
    Volume104
    Issue number2
    DOIs
    Publication statusPublished - 2007

    Fingerprint

    Clenbuterol
    Leukocytes
    Basophils
    Eosinophils
    Monocytes
    Neutrophils
    Adrenergic Agonists
    Lymphocyte Count
    Adrenergic Receptors
    Sports
    Immune System
    Asthma
    Lymphocytes
    Control Groups

    Keywords

    • β-agonist
    • Clenbuterol
    • Immune-responsive system
    • Lymphocyte
    • White blood cell

    ASJC Scopus subject areas

    • Pharmacology

    Cite this

    Shirato, K., Tanihata, J., Motohashi, N., Tachiyashiki, K., Tomoda, A., & Imaizumi, K. (2007). β2-agonist clenbuterol induced changes in the distribution of white blood cells in rats. Journal of Pharmacological Sciences, 104(2), 146-152. https://doi.org/10.1254/jphs.FP0070267

    β2-agonist clenbuterol induced changes in the distribution of white blood cells in rats. / Shirato, Ken; Tanihata, Jun; Motohashi, Norio; Tachiyashiki, Kaoru; Tomoda, Akio; Imaizumi, Kazuhiko.

    In: Journal of Pharmacological Sciences, Vol. 104, No. 2, 2007, p. 146-152.

    Research output: Contribution to journalArticle

    Shirato, K, Tanihata, J, Motohashi, N, Tachiyashiki, K, Tomoda, A & Imaizumi, K 2007, 'β2-agonist clenbuterol induced changes in the distribution of white blood cells in rats', Journal of Pharmacological Sciences, vol. 104, no. 2, pp. 146-152. https://doi.org/10.1254/jphs.FP0070267
    Shirato, Ken ; Tanihata, Jun ; Motohashi, Norio ; Tachiyashiki, Kaoru ; Tomoda, Akio ; Imaizumi, Kazuhiko. / β2-agonist clenbuterol induced changes in the distribution of white blood cells in rats. In: Journal of Pharmacological Sciences. 2007 ; Vol. 104, No. 2. pp. 146-152.
    @article{b35ebefca06149e4a07c315168eeb5b5,
    title = "β2-agonist clenbuterol induced changes in the distribution of white blood cells in rats",
    abstract = "Clenbuterol [CLE: 4-amino-α(t-butyl-amino)methyl-3,5-dichlorobenzyl alcohol] is well known as a potent β2-adrenergic agonist and non-steroidal anabolic drug, and thus it is generally used for sports doping and asthma therapy. Although the functions of immune cells such as white blood cells (WBCs) have shown to be modulated through β2- adrenoceptors, the effects of CLE on immune-responsive systems have not been elucidated systematically. Therefore, the effects of CLE on the number of WBCs were studied in rats. Male adult rats were divided into CLE-administered group and the control group to compare the number of total WBCs, neutrophils, monocytes, lymphocytes, eosinophils, and basophils. The administration (dose = 1.0 mg·kg-1 body weight·day-1, s.c.) of CLE was maintained for 30 days. CLE did not change the number of total WBCs during the experimental period. However, CLE increased significantly the number of neutrophils and monocytes, while CLE decreased drastically the number of lymphocytes and eosinophils. There was no significant change in the number of basophils between both groups. These results suggest that the administration of CLE induces drastic redistribution of WBCs in circulation without changing the number of total WBCs, and these responses of WBCs during the administration of CLE are sustained for at least 30 days.",
    keywords = "β-agonist, Clenbuterol, Immune-responsive system, Lymphocyte, White blood cell",
    author = "Ken Shirato and Jun Tanihata and Norio Motohashi and Kaoru Tachiyashiki and Akio Tomoda and Kazuhiko Imaizumi",
    year = "2007",
    doi = "10.1254/jphs.FP0070267",
    language = "English",
    volume = "104",
    pages = "146--152",
    journal = "Journal of Pharmacological Sciences",
    issn = "1347-8613",
    publisher = "Japanese Pharmacological Society",
    number = "2",

    }

    TY - JOUR

    T1 - β2-agonist clenbuterol induced changes in the distribution of white blood cells in rats

    AU - Shirato, Ken

    AU - Tanihata, Jun

    AU - Motohashi, Norio

    AU - Tachiyashiki, Kaoru

    AU - Tomoda, Akio

    AU - Imaizumi, Kazuhiko

    PY - 2007

    Y1 - 2007

    N2 - Clenbuterol [CLE: 4-amino-α(t-butyl-amino)methyl-3,5-dichlorobenzyl alcohol] is well known as a potent β2-adrenergic agonist and non-steroidal anabolic drug, and thus it is generally used for sports doping and asthma therapy. Although the functions of immune cells such as white blood cells (WBCs) have shown to be modulated through β2- adrenoceptors, the effects of CLE on immune-responsive systems have not been elucidated systematically. Therefore, the effects of CLE on the number of WBCs were studied in rats. Male adult rats were divided into CLE-administered group and the control group to compare the number of total WBCs, neutrophils, monocytes, lymphocytes, eosinophils, and basophils. The administration (dose = 1.0 mg·kg-1 body weight·day-1, s.c.) of CLE was maintained for 30 days. CLE did not change the number of total WBCs during the experimental period. However, CLE increased significantly the number of neutrophils and monocytes, while CLE decreased drastically the number of lymphocytes and eosinophils. There was no significant change in the number of basophils between both groups. These results suggest that the administration of CLE induces drastic redistribution of WBCs in circulation without changing the number of total WBCs, and these responses of WBCs during the administration of CLE are sustained for at least 30 days.

    AB - Clenbuterol [CLE: 4-amino-α(t-butyl-amino)methyl-3,5-dichlorobenzyl alcohol] is well known as a potent β2-adrenergic agonist and non-steroidal anabolic drug, and thus it is generally used for sports doping and asthma therapy. Although the functions of immune cells such as white blood cells (WBCs) have shown to be modulated through β2- adrenoceptors, the effects of CLE on immune-responsive systems have not been elucidated systematically. Therefore, the effects of CLE on the number of WBCs were studied in rats. Male adult rats were divided into CLE-administered group and the control group to compare the number of total WBCs, neutrophils, monocytes, lymphocytes, eosinophils, and basophils. The administration (dose = 1.0 mg·kg-1 body weight·day-1, s.c.) of CLE was maintained for 30 days. CLE did not change the number of total WBCs during the experimental period. However, CLE increased significantly the number of neutrophils and monocytes, while CLE decreased drastically the number of lymphocytes and eosinophils. There was no significant change in the number of basophils between both groups. These results suggest that the administration of CLE induces drastic redistribution of WBCs in circulation without changing the number of total WBCs, and these responses of WBCs during the administration of CLE are sustained for at least 30 days.

    KW - β-agonist

    KW - Clenbuterol

    KW - Immune-responsive system

    KW - Lymphocyte

    KW - White blood cell

    UR - http://www.scopus.com/inward/record.url?scp=34250804721&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=34250804721&partnerID=8YFLogxK

    U2 - 10.1254/jphs.FP0070267

    DO - 10.1254/jphs.FP0070267

    M3 - Article

    VL - 104

    SP - 146

    EP - 152

    JO - Journal of Pharmacological Sciences

    JF - Journal of Pharmacological Sciences

    SN - 1347-8613

    IS - 2

    ER -